No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon

Share this content:
No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon
No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon

FRIDAY, Dec. 30, 2016 (HealthDay News) -- For patients undergoing autologous breast reconstruction, the incidence of chronic postsurgical pain (CPSP) does not differ for patients receiving transversus abdominis plane (TAP) catheters delivering bupivacaine or saline bolus, according to a study published online Dec. 20 in Pain Practice.

Justin Oh, from the Toronto General Hospital, and colleagues conducted a prospective follow-up study to compare the incidence of CPSP after autologous breast reconstruction between patients who received postoperative intermittent TAP catheters with bupivacaine or saline boluses. Participants included 93 patients who underwent deep inferior epigastric artery perforator or muscle-sparing transverse rectus abdominis breast reconstruction and were randomly allocated to receive TAP catheters with bupivacaine or saline.

The researchers found that at six and 12 months after surgery, 24 and 23 percent of patients reported CPSP, respectively. Pain-related variables, including incidence of CPSP, did not differ between the groups. The likelihood of having CPSP was increased at six months, but not at 12 months, among patients who reported greater variability in pain scores at rest over the first 48 hours postoperatively.

"Neither postoperative use of bupivacaine vs. saline in the TAP catheters nor acute pain severity influenced the six- or 12-month incidence of CPSP," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »